Matthew Hart to Combined Modality Therapy
This is a "connection" page, showing publications Matthew Hart has written about Combined Modality Therapy.
Connection Strength
0.037
-
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. RNA Biol. 2018; 15(11):1420-1432.
Score: 0.037
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.